Citation Impact
Citing Papers
Endovascular versus Open Repair of Abdominal Aortic Aneurysm
2010 Standout
Estimating the reproducibility of psychological science
2015 StandoutScience
Laparoscopy versus laparotomy for the management of early stage cervical cancer
2015
Assessing the potential for outcome reporting bias in a review: a tutorial
2010
SYRCLE’s risk of bias tool for animal studies
2014 Standout
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
2010 Standout
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
2007
Tiagabine
1998
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Many scenarios exist for selective inclusion and reporting of results in randomized trials and systematic reviews
2013
Ethical issues posed by cluster randomized trials in health research
2011
Monostars: An Aid to Choosing an Antiepileptic Drug as Monotherapy
1999
Whole Animal Experiments Should Be More Like Human Randomized Controlled Trials
2013
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
2007
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors
2005
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010
Early Identification of Refractory Epilepsy
2000 Standout
How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data
2009 Standout
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias — An Updated Review
2013
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Ethical issues in the design and conduct of cluster randomised controlled trials
1999
Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine
2003
Identification of Additional Trials in Prospective Trial Registers for Cochrane Systematic Reviews
2012
Standardising outcomes for clinical trials and systematic reviews
2007
An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta‐analysis of time‐to‐event outcomes
2005
Meta-analysis of rare and adverse event data
2002
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
2004
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
2010
Bias Due to Changes in Specified Outcomes during the Systematic Review Process
2010
Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study
2011
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Specific reading disability (dyslexia): what have we learned in the past four decades?
2004 Standout
Pancreatic Adenocarcinoma
2014 Standout
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy
1999
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Are distinctive ethical principles required for cluster randomized controlled trials?
2001
Application and investigation of a bound for outcome reporting bias
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials
2004
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols
2008
Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data
2007
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
2005
Recent developments in meta‐analysis
2007
Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales
2002
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry
2008
Development and behaviour of low‐birthweight term infants at 8 years in northeast Brazil: A longitudinal study
2006
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Quantity and Reporting Quality of Kidney Research
2018
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Alzheimer's Disease
2010 Standout
A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients*
2005
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta‐analysis with zero cells
2008
Patient Preference for Surgical Method of Abdominal Aortic Aneurysm Repair: Postal Survey
2009
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
2008
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Pancreatic Cancer
2010 Standout
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
2010 Standout
Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale
2003
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention
2014
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Estimation of the survival function for Gray's piecewise‐constant time‐varying coefficients model
2002
Effect size, confidence interval and statistical significance: a practical guide for biologists
2007 Standout
Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives
2005
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Herpes Zoster
2013 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
2015
The Effects of Probiotic Supplementation on Experimental Acute Pancreatitis: A Systematic Review and Meta-Analysis
2012
Practical methods for incorporating summary time-to-event data into meta-analysis
2007 Standout
Identification and impact of outcome selection bias in meta‐analysis
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Improving the quality of reporting in randomised controlled trials
2004
Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO
2011
Comparison of protocols and registry entries to published reports for randomised controlled trials
2011
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions
2014
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
Multilevel models for meta-analysis, and their application to absolute risk differences
2001
The inclusion of reports of randomised trials published in languages other than English in systematic reviews
2003
An exploratory test for an excess of significant findings
2007
Catalytic Asymmetric Synthesis of Unprotected β2-Amino Acids
2021 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
2018 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Publication bias in clinical trials due to statistical significance or direction of trial results
2009 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
How common are the “common” neurologic disorders?
2007
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Jane L. Hutton being referenced
Implications of socio-cultural contexts for the ethics of clinical trials.
1997
Magnocellular visual function and children's single word reading
1998
Levetiracetam add-on for drug-resistant localization related (partial) epilepsy
2001
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials
2002
Multiple birth and cerebral palsy in Europe: a multicenter study
2004
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review
2001
Maximising response to postal questionnaires – A systematic review of randomised trials in health research
2006
Fraud in Medical Research
2000
Cerebral palsy and intrauterine growth in single births: European collaborative study
2003
Some Popular Versions of Uninformed Consent
2000
Aggregate data meta‐analysis with time‐to‐event outcomes
2002
Investigation of within‐study selective reporting in clinical research: follow‐up of applications submitted to a local research ethics committee
2002
Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies
2000
Ethical issues in implementation research: a discussion of the problems in achieving informed consent
2008
The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability
1997
Differential effects of preterm birth and small gestational age on cognitive and motor development
1997
Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals
2009
Ethics of medical research in developing countries: the role of international codes of conduct
2000
Number Needed to Treat: Properties and Problems
2000
Statistical Review by Research Ethics Committees
2000
Parameter Orthogonality in Mixed Regression Models for Survival Data
1997
Bias in Meta-Analysis Due to Outcome Variable Selection Within Studies
2000
Topiramate add-on for drug-resistant partial epilepsy
2014
Issues in methodological research: perspectives from researchers and commissioners
2001
Outcome selection bias in meta-analysis
2005